Attention Training for COVID-19 Related Distress - Trial NCT06267313
Access comprehensive clinical trial information for NCT06267313 through Pure Global AI's free database. This phase not specified trial is sponsored by Palo Alto University and is currently Not yet recruiting. The study focuses on Anxiety. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Palo Alto University
Timeline & Enrollment
N/A
Feb 19, 2024
Feb 19, 2026
Primary Outcome
COVID-19 Anxiety Syndrome Scale,COVID-19 Anxiety Syndrome Scale,COVID-19 Anxiety Syndrome Scale,COVID-19 Anxiety Syndrome Scale
Summary
The study aims to test whether attention training (attention bias modification or attention
 control training) reduces distress or COVID-19 related anxiety compared to a neutral
 condition.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06267313
Non-Device Trial